Too many acronyms? Not to worry. It is all perfectly clear in the news release we just sent out about this. A new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan Zuckerberg Initiative (CZI) will advance scientific efforts to respond to the COVID-19 pandemic by collaborating on disseminating single-cell research that … Continue reading CIRM & CZI & MOU for COVID-19
Dr. Justin Ichida
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Coronavirus particles, illustration. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19. Dr. Michael Mathay, of the University of California at San Francisco, was awarded $750,000 for a clinical trial testing … Continue reading CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Dr. Justin Ichida, Assistant Professor at USC and lead author of the study Scientists have long tried to repurpose cells in order to potentially treat various types of conditions. This process, called reprogramming, involves changing one type of cell into another, such as a blood cell into a muscle cell or nerve cell. Although the … Continue reading Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
The Stem Cellar 